For some time now, Teva Pharmaceutical Industries—like many other pharmas recently—has been having the occasional chat with the Justice Department about what the latter sees as some pretty wide-ranging price fixing. While this is fairly widespread in the industry, it is also illegal, and according to the Feds, Teva’s been doing a whole lot of it: On arthritis, blood clot, cholesterol, cystic fibrosis, hypertension, pain, seizure skin condition drugs. Oh yea, and brain cancer. That, too. All the tune of $350 million extra in the bank.